We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEN
4301
Tsakos Energy Navigation Ltd
TEN
$1.23B
$10.1K ﹤0.01%
453
-839
-65% -$17.9K
COCP icon
4302
Cocrystal Pharma
COCP
$15.2M
$10.1K ﹤0.01%
5,844
+2,496
+75% +$4.44K
CODX
4303
Co-Diagnostics
CODX
$5.49M
$10.1K ﹤0.01%
252
+159
+171% +$5.61K
KPTI icon
4304
Karyopharm Therapeutics
KPTI
$45.1M
$10K ﹤0.01%
774
-702
-48% -$9.46K
ARKF icon
4305
ARK Blockchain & Fintech Innovation ETF
ARKF
$782M
$10K ﹤0.01%
+364
New +$8.02K
NGM
4306
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$10K ﹤0.01%
11,682
-16,216
-58% -$14.2K
KWY
4307
Kingsway Corp
KWY
$283M
$10K ﹤0.01%
1,194
+1,190
+29,750% +$9.01K
XPH icon
4308
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
$10K ﹤0.01%
241
+235
+3,917% +$8.9K
EVA
4309
DELISTED
Enviva Inc.
EVA
$10K ﹤0.01%
10,047
+1,689
+20% +$4.69K
INO icon
4310
Inovio Pharmaceuticals
INO
$93M
$10K ﹤0.01%
1,634
-1,429
-47% -$7.05K
MQY icon
4311
BlackRock MuniYield Quality Fund
MQY
$816M
$10K ﹤0.01%
+820
New +$9.01K
URA icon
4312
Global X Uranium ETF
URA
$6.31B
$10K ﹤0.01%
361
+129
+56% +$3.54K
LBPH
4313
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$9.99K ﹤0.01%
1,656
-2,639
-61% -$13.2K
RAIN
4314
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$9.98K ﹤0.01%
8,316
+1,969
+31% +$2.13K
VNRX icon
4315
VolitionRx Ltd
VNRX
$7.6M
$9.97K ﹤0.01%
696
+294
+73% +$4.32K
CTXR icon
4316
Citius Pharmaceuticals
CTXR
$20.1M
$9.97K ﹤0.01%
527
-129
-20% -$2.45K
SKYX icon
4317
SKYX Platforms
SKYX
$148M
$9.97K ﹤0.01%
6,231
-8,893
-59% -$13.8K
EDV icon
4318
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
$9.97K ﹤0.01%
+123
New +$8.8K
CPBI icon
4319
Central Plains Bancshares
CPBI
$87.6M
$9.95K ﹤0.01%
+975
New +$9.42K
CWBC
4320
Community West Bancshares
CWBC
$706M
$9.95K ﹤0.01%
445
-1,166
-72% -$20.4K
XT icon
4321
iShares Future Exponential Technologies ETF
XT
$4.01B
$9.94K ﹤0.01%
166
+69
+71% +$3.72K
FTCI icon
4322
FTC Solar
FTCI
$40.1M
$9.94K ﹤0.01%
1,434
+900
+169% +$8.17K
THCH icon
4323
TH International
THCH
$51.3M
$9.93K ﹤0.01%
+1,135
New +$9.97K
GROW icon
4324
US Global Investors
GROW
$38.8M
$9.93K ﹤0.01%
3,522
+192
+6% +$545
PARAP
4325
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$9.93K ﹤0.01%
+531
New +$9.64K
171 172
173
174 175

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.